The American Society for Preventive Cardiology (ASPC) is a multidisciplinary membership organization that promotes the prevention of cardiovascular disease, advocates for the preservation of cardiovascular, disseminates high-quality, evidence-based information through education of healthcare clinicians and their patients. If you work lies within the boundaries of prevention, ASPC membership is a powerful way to improve your scope of activity and further your career objectives. Learn More what ASPC Membership can do for you at: www.aspconline.org/membership/member-benefits/
SGLT2 Inhibitors, Combination Therapy Needed to Stem the Tide of CKD in DiabetesAugust 20th 2022
Katherine R. Tuttle, MD, FASN, FACP, FNKF, a nephrologist from the University of Washington and Providence Health Care, discussed new consensus guidelines that call for the early use of sodium glucose cotransporter 2 (SGLT2) inhibitors, GLP-1 receptor agonists, and finerenone in the care of patients with both chronic kidney disease (CKD) and diabetes.
As Health Disparities “Weave Their Way Through Hypertension,” New Agents Are on the WayAugust 8th 2022
Coverage from the 2022 Congress of the American Society for Preventive Cardiology (ASPC) in Louisville, Kentucky, featuring 3 experts on aspects of hypertension treatment: Keith C. Ferdinand, MD, of Tulane University School of Medicine; Kim Allan Williams, MD, of the University of Louisville; and George C. Bakris, MD, of the University of Chicago Medicine.
Cardiologists Must “Get Into the Game” With Novel Agents in Patients With DiabetesAugust 3rd 2022
During the 2022 Congress of the American Society for Preventive Cardiology (ASPC), held in Louisville, Kentucky, Erin D. Michos, MD, MHS, of Johns Hopkins, and Pam R. Taub, MD, of UC San Diego Health, discussed how treatment of diabetes requires going beyond glucose-lowering therapies and including newer medications that offer cardiovascular benefits.
Gulati on Unequal CV Treatment for Women: “There Is a Bias in Our Care”August 1st 2022
Martha Gulati, MD, MS, kicked off the symposium “Saving the Hearts of Women Through Prevention” ahead of the 2022 Congress of the American Society for Preventive Cardiology, which took place Friday through Sunday in Louisville, Kentucky.
Social Determinants, Including Racism, Are Major Drivers of Health Inequity, Watson SaysJuly 31st 2022
Social determinants of health are major drivers of the inequities seen in health outcomes, and racism is clearly a social determinant tied to life expectancy, said Karol Watson, MD, PhD, in talk Sunday at the 2022 Congress of the American Society for Preventive Cardiology, held in Louisville, Kentucky.
Gluckman Calls for Better Data, Payer Policies to Drive Value-Based CV CareJuly 30th 2022
Ty J. Gluckman, MD, FACC, FAHA, who is medical director of the Center for Cardiovascular Analytics, Research, and Data Science at Providence St. Joseph Health in Portland, Oregon, addressed the 2022 Congress of the American Society for Preventive Cardiology meeting in Louisville, Kentucky.
Duke’s Douglas Highlights Need for Respect in Promoting Diversity, Health EquityJuly 30th 2022
Duke University’s Pamela S. Douglas, MD, spoke to cardiology professionals who gathered for the start of the 2022 Congress of the American Society for Preventive Cardiology (ASPC), in Louisville, Kentucky.
ASPC Announces Official Program Covering the ABCs of Preventive Cardiology at Premier Annual Congress on CVD PreventionJune 30th 2022
The American Society for Preventive Cardiology (ASPC) has announced the official program for the ASPC 2022 Congress on CVD Prevention, scheduled July 29-31, 2022 in Louisville, Kentucky.